HEALTH OUTCOMES AND FACTORS AFFECTING LONG COVID-19 OF PATIENTS IN TAKHLI HOSPITAL, NAKHON SAWAN
DOI:
https://doi.org/10.69598/tbps.20.2.131-143Keywords:
long covid-19, factors, clinical outcome, quality of lifeAbstract
This analytical observational study was conducted at Takhli Hospital, Nakhon Sawan, Thailand, to review the symptoms, quality of life and other factors of 150 individuals who had COVID-19. Then, a between-group comparison was made of these same individuals who, subsequently, developed symptoms of long COVID-19. Symptomatic data was collected using the hospital’s medical records and on a questionnaire that was administered through telephone interviews. The participants were divided into two groups: Group 1 (129 individuals) who did not experience long COVID-19 and Group 2 (21 individuals) who experienced long COVID-19. The most common symptoms of long COVID-19 were cough (47.62%), dyspnea (19.05%), and fatigue (14.29%). The EuroQol Visual Analogue Scale (EQ-VAS) revealed that the group with long COVID-19 had lower average EQ-VAS scores and utility values compared to the group without long COVID-19. The average EQ-VAS score for the long COVID-19 group was 71.90 ± 6.93, and the utility value was 0.68 ± 0.12. Whereas, the EQ-VAS score for the group without long COVID-19 was 95.14 ± 4.51, and the utility value was 0.95 ± 0.06. Risk factors associated with long COVID-19 were analyzed using binary logistic regression. The model had an accuracy of 86%. Statistically significant risk factors (p<0.05) associated with long COVID-19 included underlying diseases and the severity of illness during the COVID-19 infection. Individuals with underlying diseases were 5.92 times more likely to experience long COVID-19 compared to those without underlying diseases. Similarly, individuals with a moderate to severe illness during COVID-19 infection were 12.59 times more likely to develop long COVID-19 compared to those with a mild illness.
References
World Health Organization. WHO Coronavirus (COVID-19) dashboard 2023 [Internet]. [updated 2024 Dec 16; cited 2024 Dec 16]. Available from: https://covid19.who.int
Ministry of Public Health. Dashboard situation of COVID-19 patients in Thailand,2021 [Internet]. [updated 2024 Dec 16; cited 2024 Dec 16]. Available from: https://ddc.moph.go.th/covid19-dashboard/
Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS, et al. Symptoms, complications and management of long COVID: A review. J R Soc Med. 2021;114(9):428-42.
Jandhyala R. Design, validation and implementation of the post-acute (long) COVID-19 quality of life (PAC-19QoL) instrument. Health Qual Life Outcomes. 2021;19(1):229.
Malik P, Patel K, Pinto C, Jaiswal R, Tirupathi R, Pillai S, et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-A systematic review and meta-analysis. J Med Virol. 2022;94(1):253-62.
Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci Rep. 2021;11(1):16144.
Shanbehzadeh S, Tavahomi M, Zanjari N, Ebrahimi-Takamjani I, Amiri-Arimi S. Physical and mental health complications post-COVID-19: Scoping review. J Psychosom Res. 2021;147:110525.
Menges D, Ballouz T, Anagnostopoulos A, Aschmann HE, Domenghino A, Fehr JS, et al. Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study. PLoS One. 2021;16(7):e0254523.
Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al. Characterising long COVID: A living systematic review. BMJ Glob Health. 2021;6(9).
Amdal CD, Pe M, Falk RS, Piccinin C, Bottomley A, Arraras JI, et al. Health-related quality of life issues, including symptoms, in patients with active COVID-19 or post COVID-19; A systematic literature review. Qual Life Res. 2021;30(12):3367-81.
Figueiredo EAB, Silva WT, Tsopanoglou SP, Vitorino DFM, Oliveira LFL, Silva KLS, et al. The health-related quality of life in patients with post-COVID-19 after hospitalization: A systematic review. Rev Soc Bras Med Trop. 2022;55:e0741.
Tsuzuki S, Miyazato Y, Terada M, Morioka S, Ohmagari N, Beutels P. Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients. Health Qual Life Outcomes. 2022;20(1):125.
Líška D, Liptaková E, Babičová A, Batalik L, Baňárová PS, Dobrodenková S. What is the quality of life in patients with long COVID compared to a healthy control group? Front Public Health. 2022;10:975992.
Soprakhon K, Inthidet K, Wangpradit O, Duangsin A, Nak-ai W.Factors related to Long COVID in people with a history of COVID-19 infection in Ang Sila Sub-district, Mueang District, Chonburi Province. JODPC10. 2023;21(2):83-96. (in Thai)
Tancharoensukjit T. Prevalence and factors associated with post acute COVID syndrome (long COVID) in patients infected Coronavirus disease 2019 who received inpatient treatment Lan Krabue Hospital. J Dept Med Serv. 2023;48(1):51-9. (in Thai)
Woravutrangkul S, Chukijrungroat N.. Impacts of post-COVID-19 on common symptoms, functional capacity, pulmonary function and quality of life following 6 months after infection in young adult. J Health Sci Thai. 2024;33(2):199-207. (in Thai)
Jirapatarachottmanee J. Factors related to Long COVID-19 among personal at Nakhon Pathom Hospital. J Environ Public Health. 2024;9(4):698-707. (in Thai)
Hajicheteh W. Incidence and factors associated with long Covid in patients infected with Covid-19 treated at Khok Pho Hospital. J Educ Res Public Health. 2023;1(3):174-85. (in Thai)
Thgurngsakdakul S. Factors associated with post-Covid conditions in Nangrong Hospital, Buriram Province. Med J Sisaket Surin Buriram Hosp. 2023;38(2):449-61. (in Thai)
Ministry of Public Health. Gluideline for treatment of Post COVID for public health personel [Internet]. [updated 2021 Dec 16; cited 2024 Feb 23]. Available from: https://covid19.dms.go.th/backend/Content/Content_File/Covid_Health/Attach/25650126100932AM_การดูแลรักษาผู้ป่วย%20Long%20COVID%20v.2.4.pdf (in Thai)
Downloads
Published
How to Cite
Issue
Section
License
All articles published and information contained in this journal such as text, graphics, logos and images is copyrighted by and proprietary to the Thai Bulletin of Pharmaceutical Sciences, and may not be reproduced in whole or in part by persons, organizations, or corporations other than the Thai Bulletin of Pharmaceutical Sciences and the authors without prior written permission.